Fuda Cancer Hospital-Guangzhou, located in Guangzhou, Guangdong Province, China, is a leading institution specializing in comprehensive cancer care. Established in 2001, the hospital has been at the forefront of providing high-quality cancer treatment, integrating advanced medical technology with patient-centered care. It is committed to offering innovative treatments and personalized care for patients suffering from various types of cancer.

• Cryosurgical Ablation (CSA): Destroys tumors with extreme cold.

• Irreversible Electroporation (IRE): Uses electrical pulses to target tumors.

• Cancer Vascular Intervention (CVI): Delivers chemotherapy directly to tumors.

• Combined Immunotherapy (CIC): Boosts the immune system to fight cancer.

• Brachytherapy: Delivers targeted radiation via implanted radioactive seeds.

• Photodynamic Therapy (PDT): Uses light-activated drugs to destroy cancer cells.

• JCI Accreditation: Achieved Joint Commission International (JCI) accreditation in 2014, ensuring adherence to global healthcare standards. ​

• National Recognition: Designated as a National Key Clinical Specialty (Oncology) Hospital by the Chinese government in 2010

• Mission: Provide innovative and minimally invasive cancer treatments to enhance patient comfort and survival rates.​

• Vision: Be recognized globally for excellence in cancer treatment and research, offering personalized care to patients worldwide.

• 2014: Role Model of the Times award for Chief President Xu Kecheng.

• 2008: Gold Medal from the Japan Society for Low Temperature Medicine.

• 2007: ISC Special Award for contributions to cryosurgery.

• 2011: National Key Clinical Cancer Specialty Center recognition.

• 2011: National Trustworthy Private Hospital designation.

• 2012: China Public Confidence Model Hospital award.

• 2014: JCI Accreditation for meeting global healthcare standards.